spacer
home > pmps > summer 2007 > intuitive packaging
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Intuitive Packaging

Hans-Erik Gording at Bang & Olufsen Medicom asks, can medical device enhancement of packaging really improve patient outcomes?

“Drugs don’t work in patients who don’t take them.” This well known quotation from former US Surgeon General C Everett Coop may state the obvious, but the impact and consequences of noncompliance are both widespread and far reaching. The WHO report on adherence to long-term treatments, published in 2003, showed that approximately half of all medications prescribed for chronic illnesses, such as hypertension or hypercholesterolemia, was not taken appropriately. This has a huge impact on all stakeholders, be it the patient, the healthcare providers or society as a whole.

WHAT IS PATIENT COMPLIANCE?

Drug regime compliance is defined as the degree of correspondence between actual dosing history and the prescribed regimen. This means that the administration-intake of a correct dose of the drug must take place at a defined time (compliance), and that the patient will continue doing so for the whole period of treatment (persistence). Typically, patients will accommodate dosing intake time within their routine, and can frequently forget to take medication.

COMPLIANCE MONITORING

Compliance monitoring is an important factor in both clinical trials and everyday intake of medication. However, clinical papers report an alarming discrepancy between patient reported and actual medication compliance and, as such, electronic monitoring of patient compliance is widely accepted as the gold standard (1), although it is frequently not applied in clinical trials. Good knowledge and improvement of patient compliance can have a significant effect on patient outcomes in clinical trials. In addition, higher compliance rates can significantly reduce the required sample size, number of study sites and, potentially, the duration of clinical studies from first patient in to last patient out. The following methods are used in monitoring patient compliance.

Compliance monitoring is an important factor in both clinical trials and everyday intake of medication. However, clinical papers report an alarming discrepancy between patient reported and actual medication compliance and, as such, electronic monitoring of patient compliance is widely accepted as the gold standard (1), although it is frequently not applied in clinical trials. Good knowledge and improvement of patient compliance can have a significant effect on patient outcomes in clinical trials. In addition, higher compliance rates can significantly reduce the required sample size, number of study sites and, potentially, the duration of clinical studies from first patient in to last patient out. The following methods are used in monitoring patient compliance.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Hans-Erik Gording is an International Key Account Manager at Bang & Olufsen Medicom, an associated medical device technology company of the Danish audio visual group Bang & Olufsen. Hans-Erik joined Bang & Olufsen Medicom in 2005, following 10 years of experience within the pharmaceutical industry working within sales, training, key opinion leader development and business development roles.
spacer
Hans-Erik Gording
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals enters into manufacturing agreement with the Swedish company Affibody

[Noáin, May 27, 2019] 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Swedish company Affibody for the process transfer, scale-up and GMP commercial manufacturing of a recombinant protein sole property of Affibody.
More info >>

White Papers
 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement